Found 7 matching trials
Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy PHASE2 The aim of this study is to assess the progression free survival (PFS) of S...
Show More Location
Royal North Shore
Learn More & Join Trial
Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study N/A The goal of this observational study (multicenter, national registry-based)...
Show More Location
University Hospital Basel
Learn More & Join Trial
Targeted Radionuclide Therapy in Metastatic Prostate Cancer Using a New PSMA Ligand Radiolabelled With Terbium-161 (161Tb-SibuDAB) - Dose Identification/Escalation Phase Ia/b Study PHASE1 Researchers will test a new treatment for prostate cancer. This treatment u...
Show More Location
University Hospital Basel
Learn More & Join Trial
68Ga/177Lu-PSMA Theranostics in Recurrent Grade 3 and Grade 4 Glioma NA This interventional, clinical pilot-study will initiate and evaluate 68Ga/1...
Show More Location
St. Olavs hospital
Learn More & Join Trial
Radiometabolic Therapy With 177Lu PSMA in PSMA PET/CT Positive Advanced/Metastatic Tumours: PHASE2 Phase 2 study, single arm trial enrolling patients with a Gallium-68/Fluori...
Show More Status
Active Not Recruiting
Location
UO Medicina Nucleare, IRCCS IRST
Learn More & Join Trial
Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients PHASE2 In this study it is aimed to analyze the efficacy and safety of Tb-161 PSMA...
Show More Location
Ankara University Medical School Dept of Nuclear Medicine
Learn More & Join Trial
177Lu-PSMA-I&T Prior to Radical Prostatectomy for Locally Advanced Disease NA Despite surgical advances, up to 50% of patients with high-risk locally adv...
Show More Location
Rabin Medical Center, Beilinson hospital
Learn More & Join Trial